C

LeMaitre Vascular, Inc. LMAT

$78.29 $0.640.82% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$77.91$80.21
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

LMAT Rating

Reward
Risk

LMAT Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

LMAT Company Overview

LeMaitre Vascular, Inc. is a U.S.-based medical device company focused on the treatment of peripheral vascular disease and the broader vascular surgery market. The company develops, manufactures, and markets medical devices and biologic products used by vascular surgeons, cardiovascular surgeons, and other specialists for open vascular surgery procedures. Its operations are concentrated in the medical technology and vascular device industries, with revenue primarily generated through the sale of disposable surgical devices, implantable products, biologic patches, grafts, and related vascular instruments.

The company’s portfolio includes products for carotid shunting, vessel sealing, embolectomy, thrombectomy, biologic patches, vascular grafts, valvulotomes, and anastomotic devices. LeMaitre Vascular has positioned itself as a specialized provider serving a relatively focused segment of the medical device market, emphasizing niche vascular surgery products rather than broad-based cardiovascular platforms. Founded in 1983 by vascular surgeon George W. LeMaitre, the company expanded through a combination of internal product development and acquisitions of complementary vascular technologies. Public filings and investor materials indicate that its strategy has historically emphasized recurring procedural demand, surgeon-focused innovation, and targeted acquisitions within vascular surgery.

Data compiled by narrative technology. May contain errors.
Sector

LMAT Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

LMAT Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

LMAT Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

LMAT Price History

Loading...
52-Week Range2% of range
Current
$78.29
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

LMAT Valuation

Market Cap
Market Cap Rank
#5,738
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

LMAT Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

LMAT Corporate Info

Phone Number
781 221 2266
Address
63 Second Avenue
Burlington, MA 01803
Country
Year Founded

LMAT Filings

Filing Date
Thursday, November 5, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 22 and 26 (est)

LMAT Headlines

11/4/2026 - Zacks Investment Research
11/4/2026 - Globe Newswire